![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](bt2843contents.gif)
Acta Cryst. (2009). E65, o363 [ doi:10.1107/S1600536809002037 ]
Abstract: The title compound, C17H13NO, synthesized to be tested for neuroprotective activities, consists of an indoline and a phenylallylidene unit with a dihedral angle of 9.0 (1)° between the two ring systems. There are two independent molecules in the asymmetric unit which are connected into a dimer by intermolecular N-H
O hydrogen bonds.
Online 23 January 2009
Copyright © International Union of Crystallography
IUCr Webmaster